The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serum microRNAs to predict the response to nivolumab in patients with esophageal squamous cell carcinoma.
 
Kazuki Sudo
No Relationships to Disclose
 
Ken Kato
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Merck Serono (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Juntaro Matsuzaki
No Relationships to Disclose
 
Junpei Kawauchi
Employment - Toray Industries
Patents, Royalties, Other Intellectual Property - Toray Industries
 
Satoko Takizawa
Employment - Toray Industries
Patents, Royalties, Other Intellectual Property - Toray Industries
 
Takahiro Miyamoto
No Relationships to Disclose
 
Hirokazu Shoji
No Relationships to Disclose
 
Satoru Iwasa
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Merck Serono (Inst)
 
Yoshitaka Honma
Honoraria - Teijin Pharma
Speakers' Bureau - Daiichi Sankyo; Nihonkayaku; Novartis; Taiho Pharmaceutical
Research Funding - AstraZeneca Japan (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); Novartis (Inst); Teijin Pharma (Inst)
 
Atsuo Takashima
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Gilead Sciences (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst)
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - NanoCarrier
Research Funding - Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); MSD (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)
 
Fumitaka Takeshita
No Relationships to Disclose
 
Hiromi Sakamoto
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takahiro Ochiya
Research Funding - InterStim (Inst); Kwandong (Inst); Rohto Pharmaceutical (Inst)